Eli Lilly is buying a rare blood cancer biotech for up to $1.5 billionBusinessNov 16 at 6:34 AM – Nov 16 at 12:25 PM3 outletsBloombergLilly Pushes Buying Spree Beyond $32B With Calytrix Deal Nov 16 at 12:25 PMEli Lilly Agrees to Buy Calytrix Bio for Up to $1.5 Billion Nov 16 at 7:05 AMQuartzEli Lilly is buying a rare blood cancer biotech for up to $1.5 billion Nov 16 at 9:00 AMBusiness PostEli Lilly to acquire Calytrix Bio in deal worth up to $1.5bn Nov 16 at 6:34 AM